RE: Filling the Void22 Jun 2022 08:55
I would take it with a pinch of salt if it was just LR spouting off about Ranger. But as we know it isn't. Ranger now has cred from the likes of Laval and Labcorp. They have stumbled onto a winner imv, hence why they are very excited about it . Labs have already switched not even knowing about the cost savings at the time. With Scott leading things in the US, then they have a very good chance Ranger will succeed. Nipt is one thing, but just look at the potential in the oncology space!